These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22230575)

  • 1. Protein engineering for therapeutics, part B. Preface.
    Wittrup KD; Verdine GL
    Methods Enzymol; 2012; 503():xiii-xiv. PubMed ID: 22230575
    [No Abstract]   [Full Text] [Related]  

  • 2. Advancing protein therapeutics: current challenges in protein therapeutics -- CHI's Second Annual Conference.
    He M
    IDrugs; 2006 Mar; 9(3):177-8. PubMed ID: 16523380
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant therapeutic proteins: production platforms and challenges.
    Dingermann T
    Biotechnol J; 2008 Jan; 3(1):90-7. PubMed ID: 18041103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in radioimmunotherapy in the age of molecular engineering and pretargeting.
    Sharkey RM; Goldenberg DM
    Cancer Invest; 2006 Feb; 24(1):82-97. PubMed ID: 16466997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of therapeutic protein in vivo activities through glycoengineering.
    Elliott S; Lorenzini T; Asher S; Aoki K; Brankow D; Buck L; Busse L; Chang D; Fuller J; Grant J; Hernday N; Hokum M; Hu S; Knudten A; Levin N; Komorowski R; Martin F; Navarro R; Osslund T; Rogers G; Rogers N; Trail G; Egrie J
    Nat Biotechnol; 2003 Apr; 21(4):414-21. PubMed ID: 12612588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of protein therapeutics.
    De Groot AS; Scott DW
    Trends Immunol; 2007 Nov; 28(11):482-90. PubMed ID: 17964218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.
    Rao BM; Lauffenburger DA; Wittrup KD
    Nat Biotechnol; 2005 Feb; 23(2):191-4. PubMed ID: 15696150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein engineering for therapeutics, Part A. Preface.
    Wittrup KD; Verdine GL
    Methods Enzymol; 2012; 502():xiii-xiv. PubMed ID: 22208991
    [No Abstract]   [Full Text] [Related]  

  • 10. Engineering better cytokines.
    Steinman L
    Nat Biotechnol; 2003 Nov; 21(11):1293-4. PubMed ID: 14595357
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma.
    Luk JM; Wong KF
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keeping dry and crossing membranes.
    Fernández A
    Nat Biotechnol; 2004 Sep; 22(9):1081-4. PubMed ID: 15340471
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing mammalian cell culture engineering using genome-scale technologies.
    Griffin TJ; Seth G; Xie H; Bandhakavi S; Hu WS
    Trends Biotechnol; 2007 Sep; 25(9):401-8. PubMed ID: 17681628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple recipe for blocking ion channels.
    Benham CD
    Nat Biotechnol; 2005 Oct; 23(10):1234-5. PubMed ID: 16211063
    [No Abstract]   [Full Text] [Related]  

  • 18. Plants tackle explosive contamination.
    Meagher RB
    Nat Biotechnol; 2006 Feb; 24(2):161-3. PubMed ID: 16465159
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibiting protein-protein interactions using designed molecules.
    Zhao L; Chmielewski J
    Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Churning out safer microbes for drug delivery.
    Syvanen M
    Nat Biotechnol; 2003 Jul; 21(7):758-9. PubMed ID: 12833095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.